Session: FP33-Insulin Signaling & Inflammation
Room 303 (Moscone Center)
Poster Board MON-847
T1D (n=34), T2D (n=13) and lean (n=12) males had IS measured by hyperinsulinemic-euglycemic clamp (expressed as M-value). Other measures included leptin, testosterone, and sex hormone binding globulin. Free androgen index (FAI) was calculated using a modified Vermeuelen-equation.
Total testosterone was not different between T1D and lean males (p = 0.729), but was lower in T2D (p < 0.01). Both T1D (p < 0.01) and T2D (p < 0.01) subjects were more IR than lean controls, and those with T2D were more IR than T1D (p < 0.01). Leptin was negatively associated with both FAI (β±SE: -21±8, p = 0.038) and total testosterone (β±SE: -108±31, p = 0.002) in T1D subjects, adjusting for Tanner stage. Leptin accounted for 19% of the variability in testosterone in T1D males (p = 0.011). In a multivariate model including Tanner stage, HbA1c, diabetes duration, BMI Z-score, M-value and Lnleptin, only leptin was associated with testosterone (p = 0.008). In a multivariate model including Tanner stage, group and Lnleptin, only leptin was associated with testosterone (β±SE = -93 ± 27, p = 0.001), and after adjustment for leptin, group differences in testosterone were no longer significant (β±SE = Type 1: 344±33, Type II: 248±75, and Lean: 224±68, p = 0.177). No relationship between M-value and FAI (p = 0.932) or total testosterone (p = 0.728) was found in T1D.
In conclusion, leptin was negatively associated with both free and total testosterone in T1D, and accounted for a portion of the testosterone variability among T1D males. In contrast to previous findings in T1D, T1D males in this cohort were not hypogonadal. Furthermore, in contrast to obese and T2D adolescent males, IR was not associated with testosterone in T1D males. These observations emphasize the importance of leptin in gonadal function and raise the possibility that relationships among IR, leptin and testosterone may differ in T1D and T2D.
Nothing to Disclose: PB, MMK, KM, KJN
*Please take note of The Endocrine Society's News Embargo Policy at http://www.endo-society.org/endo2013/media.cfm
See more of: Abstracts - Orals, Featured Poster Presentations, and Posters